These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
238 related articles for article (PubMed ID: 11860016)
1. Transcription initiation of genes associated with azole resistance in Candida albicans. Harry JB; Song JL; Lyons CN; White TC Med Mycol; 2002 Feb; 40(1):73-81. PubMed ID: 11860016 [TBL] [Abstract][Full Text] [Related]
2. Molecular mechanisms associated with Fluconazole resistance in clinical Candida albicans isolates from India. Mane A; Vidhate P; Kusro C; Waman V; Saxena V; Kulkarni-Kale U; Risbud A Mycoses; 2016 Feb; 59(2):93-100. PubMed ID: 26648048 [TBL] [Abstract][Full Text] [Related]
3. Expression of Major Efflux Pumps in Fluconazole-Resistant Candida albicans. Pourakbari B; Teymuri M; Mahmoudi S; Valian SK; Movahedi Z; Eshaghi H; Mamishi S Infect Disord Drug Targets; 2017; 17(3):178-184. PubMed ID: 28558643 [TBL] [Abstract][Full Text] [Related]
4. Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms. Sanglard D; Coste AT Antimicrob Agents Chemother; 2016 Jan; 60(1):229-38. PubMed ID: 26482310 [TBL] [Abstract][Full Text] [Related]
5. [Investigation of mutations in transcription factors of efflux pump genes in fluconazole-resistant Candida albicans strains overexpressing the efflux pumps]. Kalkandelen KT; Doluca Dereli M Mikrobiyol Bul; 2015 Oct; 49(4):609-18. PubMed ID: 26649419 [TBL] [Abstract][Full Text] [Related]
6. Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters. Sanglard D; Kuchler K; Ischer F; Pagani JL; Monod M; Bille J Antimicrob Agents Chemother; 1995 Nov; 39(11):2378-86. PubMed ID: 8585712 [TBL] [Abstract][Full Text] [Related]
7. [Investigation of the expression levels of efflux pumps in fluconazole-resistant Candida albicans isolates]. Gulat S; Doluca Dereli M Mikrobiyol Bul; 2014 Apr; 48(2):325-34. PubMed ID: 24819270 [TBL] [Abstract][Full Text] [Related]
8. ERG11 mutations and expression of resistance genes in fluconazole-resistant Candida albicans isolates. Xu Y; Sheng F; Zhao J; Chen L; Li C Arch Microbiol; 2015 Nov; 197(9):1087-93. PubMed ID: 26349561 [TBL] [Abstract][Full Text] [Related]
9. The evaluation of the overexpression of the ERG-11, MDR-1, CDR-1, and CDR-2 genes in fluconazole-resistant Candida albicans isolated from Ahvazian cancer patients with oral candidiasis. Maheronnaghsh M; Teimoori A; Dehghan P; Fatahinia M J Clin Lab Anal; 2022 Feb; 36(2):e24208. PubMed ID: 34997991 [TBL] [Abstract][Full Text] [Related]
10. Overexpression of Candida albicans CDR1, CDR2, or MDR1 does not produce significant changes in echinocandin susceptibility. Niimi K; Maki K; Ikeda F; Holmes AR; Lamping E; Niimi M; Monk BC; Cannon RD Antimicrob Agents Chemother; 2006 Apr; 50(4):1148-55. PubMed ID: 16569823 [TBL] [Abstract][Full Text] [Related]
11. Mechanisms of resistance to fluconazole in Candida albicans clinical isolates from Iranian HIV-infected patients with oropharyngeal candidiasis. Salari S; Khosravi AR; Mousavi SA; Nikbakht-Brojeni GH J Mycol Med; 2016 Mar; 26(1):35-41. PubMed ID: 26627124 [TBL] [Abstract][Full Text] [Related]
12. Cloning of Candida albicans genes conferring resistance to azole antifungal agents: characterization of CDR2, a new multidrug ABC transporter gene. Sanglard D; Ischer F; Monod M; Bille J Microbiology (Reading); 1997 Feb; 143 ( Pt 2)():405-416. PubMed ID: 9043118 [TBL] [Abstract][Full Text] [Related]
14. A novel multidrug efflux transporter gene of the major facilitator superfamily from Candida albicans (FLU1) conferring resistance to fluconazole. Calabrese D; Bille J; Sanglard D Microbiology (Reading); 2000 Nov; 146 ( Pt 11)():2743-2754. PubMed ID: 11065353 [TBL] [Abstract][Full Text] [Related]
15. Mechanisms of azole resistance in Candida albicans clinical isolates from Shanghai, China. Liu JY; Shi C; Wang Y; Li WJ; Zhao Y; Xiang MJ Res Microbiol; 2015 Apr; 166(3):153-61. PubMed ID: 25748216 [TBL] [Abstract][Full Text] [Related]
16. The genetic basis of fluconazole resistance development in Candida albicans. Morschhäuser J Biochim Biophys Acta; 2002 Jul; 1587(2-3):240-8. PubMed ID: 12084466 [TBL] [Abstract][Full Text] [Related]
17. Relative contributions of the Candida albicans ABC transporters Cdr1p and Cdr2p to clinical azole resistance. Tsao S; Rahkhoodaee F; Raymond M Antimicrob Agents Chemother; 2009 Apr; 53(4):1344-52. PubMed ID: 19223631 [TBL] [Abstract][Full Text] [Related]
18. Impact of Farnesol as a Modulator of Efflux Pumps in a Fluconazole-Resistant Strain of Černáková L; Dižová S; Gášková D; Jančíková I; Bujdáková H Microb Drug Resist; 2019; 25(6):805-812. PubMed ID: 30785845 [No Abstract] [Full Text] [Related]
19. Resistance mechanisms in clinical isolates of Candida albicans. White TC; Holleman S; Dy F; Mirels LF; Stevens DA Antimicrob Agents Chemother; 2002 Jun; 46(6):1704-13. PubMed ID: 12019079 [TBL] [Abstract][Full Text] [Related]
20. Synthetic Organotellurium Compounds Sensitize Drug-Resistant Candida albicans Clinical Isolates to Fluconazole. Reis de Sá LF; Toledo FT; Gonçalves AC; Sousa BA; Dos Santos AA; Brasil PF; Duarte da Silva VA; Tessis AC; Ramos JA; Carvalho MA; Lamping E; Ferreira-Pereira A Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27821447 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]